Optical coherence tomography is a relatively new non-invasive imaging technique used for obtaining the images and quantifying the layers of the retina. It also provides information about optic nerve head topography, peripapillary retinal nerve fi ber layer thickness, and macular volume which correlates with axonal loss. Until now, this method was used mainly in ophthalmology; now it has emerged as relevant in neurology as well. RNFL thickness is of particular interest in optic neuropathies and in multiple sclerosis. In sclerosis multiplex, axonal loss occurs as early as the fi rst stages and the quantifi cation of the RNFL thickness by OCT provides an indirect measure of axonal and neuronal loss in the anterior visual pathways. Because OCT is noninvasive, easy to obtain, and highly reproducible, it can be used as a marker of axonal loss and as an endpoint in clinical trials. This paper presents a comprehensive summary of the use of this new diagnostic method in multiple sclerosis patients (Fig. 1, Ref. 58 ). Text in PDF www.elis.sk.
What is optical coherence tomography?
Optical Coherence Tomography (OCT) is a relatively new diagnostic method. It is a non-contact method with a great therapeutic potential, as well. Owing to its expedience, safety and a relatively low purchasing and running cost, it is used more and more in basic medical research as well as in clinical practice. Until now, this method was used mainly in ophthalmology; however, in the last ten years, it has been increasingly used in some fi elds of neurology.
One advantage of OCT is its ability to capture the image of biological tissue with high lateral resolution, based on the detection of refl ection delay and intensity of the refl ected light, with lateral resolution decoupled from axial resolution. Other advantages include its ability to render tissue structures even in highly diffusive environments, in real time, and with a resolution of 1-15 μm, which is one or two degrees higher than the resolution of conventional imaging methods like ultrasound, magnetic resonance and computer tomography. The device offers a large number of scan lines in different imaging modes and options to construct a 3D reconstruction of the retina and carry out precise metric measurements and volume calculations.
The quantifi cation of the retinal nerve fi ber layer (RNFL) thickness through OCT is an indirect measure of axonal and neuronal loss in the anterior visual pathways. Axonal degeneration in multiple sclerosis (MS) occurs as a result of infl ammation and demyelination in the early stages of the disease (1, 2) . Axonal loss is the reason behind a large part of permanent invalidity in MS patients, which is why the monitoring of axonal damage has become a priority in MS and OCT; it is a sensitive, precise and reproducible technique and is gaining greater importance and diagnostic signifi cance in neurology as well (3).
The principles of optical coherence tomography
The basic principle of OCT imaging is based on the optical technique known as Michelson low-coherence interferometry. It uses infrared light with a short coherent length, whose source is a luminescent diode. The interferometer measures phase differences between the refl ected control ray (refl ection from the reference mirror) and the ray refl ected from the tissue microstructure; the aim is to obtain a two-or three-dimensional tomography image. The principle of OCT is very similar to the ultrasound method, the only difference being that OCT works with light instead of acoustic waves (4) . OCT compares the delay of tissue refl ection with referential refl ection. The principle of image creation lies in lateral scanning of the light ray, creation of axial scans (A-scans), and subsequent combination of A-scans into the resulting image (B-scan). Thus, each A-scan carries information about the strength of the refl ected signal, or the depth of the scanned tissue.
OCT works with the wavelength of infrared lights, which eliminates the risk of glare. In creating the image of the retina, the wavelength of the light is within the range of 800-900 nm (5, 6) .
The in vivo OCT method was fi rst used to measure a retina in 1993 (7) and since then, four new generations of OCT devices have been developed. The resolution of OCT is high, in the range of 3 to 20 μm. Therefore, it has the ability to create images of very small optic structures. The third generation time domain OCT devices' resolution is in the range of 10-15 μm; the newest, fourth generation of spectral domain OCT devices pushes the quality of image detail even further and their resolution is at the level of 3 to 7 μm. Spectral OCT enables, among other things, the fast scanning of a large amount of data, combining OCT with other imaging techniques into a single image, three-dimensional reconstruction, differentiation of individual layers of the retina, and better visualization (5, 6) .
In examination using the OCT, pupillary dilation is not always necessary, as a three-millimeter pupil is adequate for obtaining the image. Good cooperation of the patient can help prevent distortion caused by eye movement. The results obtained from the exam are compared with the normative database which contains data from people considered as a representative specimen of a healthy population.
The eye as a model of neurodegenerative changes in multiple sclerosis
The most signifi cant visualized structure in neurological diseases is the retinal nerve fi ber layer (RNFL), which is the innermost layer of the retina. RNFL is composed mainly of axons of ganglion cells which are not myelinated; due to this, the retina is the only part of the CNS which can be visualized directly (8, 9, 10) . OCT, then, enables us to evaluate the impact of the pathologic process on the axons and nerve fi bers. Acute optical neuritis occurs in a one of the stages of multiple sclerosis in as many as 30 to 70 % of patients (11, 12) . Subclinical chronic optical neuropathy is also observed in some patients. The tendency of MS to affect the optic nerve is very high. In post mortem analysis, MS lesions on the optic nerve were discovered in 94-99 % of specimens from MS patients, irrespective of the history of clinical acute optical neuritis (13, 14) .
In addition to providing data about axon integrity through the measuring of RNFL thickness, OCT is also able to measure total macular volume (TMV). As the outer macula is well supplied with ganglion cell bodies, it seems that OCT evaluation of the outer macula may be able to provide an estimate of neuron integrity (mainly the ganglion cell integrity) in the retina, as well (15, 16) .
The average thickness of the RNFL in healthy subjects up to 15 years of age is approximately 110-120 μm; with aging, the thickness is reduced by about 0.017 % per year, which is equivalent to the reduction of retina thickness by 10-20-μm over 60 years (17) .
OCT and optical neuritis

Pilot studies
Optical neuritis is one of the manifestations and the second most frequent symptom of MS. Studies focusing on the treatment of optical neuritis have shown that the risk of the development of MS in patients with a diagnosed fi rst episode of infl ammation of the optic nerve is 50 % during the following 15 years. The risk rises to 72 % in patients with at least one demyelinating lesion visible in the MR image (18) .
The fi rst study documenting fi ndings from OCT eye measurements in MS patients was published in 1999. It showed that the average RNFL thickness in patients with MS and optical neuritis is much smaller than in healthy subjects. RNFL thickness was reduced by an average of 46 % in the group with optical neuritis vs. the group of control subjects, and by an average of 28 % in comparison with the patient's opposite, unaffected eye (19) .
The authors of the study from 2005 have confi rmed a 33 % reduction of RNFL thickness in the affected eyes of those patients who have suffered from acute optical neuritis vs. control subjects' eyes, and an average 27 % reduction in the comparison of affected and unaffected eyes of the same patient. In addition, they discovered that in patients with MS and optical neuritis, the macular volume measured after the optical neuritis episode was also signifi cantly lower. They proved that the thinning of the RNFL correlated more with the visual evoked potentials of the P100 wave amplitude (axonal integrity image) than the latency of the P100 wave (myelin integrity image) (20) ; this supports the hypothesis that RNFL thinning refl ects axonal degeneration.
RNFL thickness in acute optical neuritis
In 2006, Pro et al (21) showed that RNFL becomes signifi cantly thinner as early as 2 to 4 months after the outburst of optical neuritis. They also proved that RNFL measured at the baseline visit was slightly thicker in the eye with acute optical neuritis as opposed to the unaffected eye even though ophthalmoscopic exams of the patients did not uncover any cases of evident edema of the optic disc. These studies suggest that OCT is able to acutely diagnose even very slight disc edemas in optical neuritis. Therefore, it is good to be aware of the time elapsed between the loss of eyesight and the interpretation of OCT measurement (22) .
The development of RNFL thickness after recovery from isolated optical neuritis
Most often, the thinning of RNFL was observed through OCT in the 3rd -6th month after the development of optical neuritis (23, 24) . In about 75 % of MS patients, the reduction of RNFL thickness in the affected eye by 10-40 μm takes place during the fi rst 3-6 months after the end of acute optical neuritis. This suggests that signifi cant and fast axon degeneration follows immediately after the primary demyelination (25) . The most frequent changes on RNFL in acute optical neuritis were observed in the temporal area (14) . The stabilization of RNFL thickness occurs within 7-12 months from the beginning of the disease (23) . Unless an adequate improvement of sight in patients with more signifi cant RNFL thinning occurs within 3-6 months from the development of optical neuritis, subsequent improvement of sight can not be anticipated; therefore, all therapeutic procedures should be undertaken within the fi rst six months after the outbreak of optical neuritis (24) .
RNFL thickness and visual functions after recovery from isolated optical neuritis
In the examination of visual functions after recovery from isolated optical neuritis, Costello et al. suggested a correlation between RNFL thickness and visual acuity and visual fi eld. There was a linear correlation between RNFL thickness and visual acuity when RNFL measurements were under 70 μm; there was also a linear correlation between RNFL thickness and the average deviation in the Humphrey visual fi eld, but only with RNFL measurements under 75 μm. The studies designated 75 μm as threshold RNFL thickness, with decrease in visual functions occurring with lower values (23, 25) .
RNFL thickness in optical neuritis patients' asymptomatic eye
Numerous studies have shown that the thinning of RNFL was observed not only in the eyes with a previous episode of optical neuritis, but also in the seemingly asymptomatic opposite eyes of MS patients with a previous episode of optical neuritis, as well as in MS patients with no recorded clinical case of acute optical neuritis (26, 27, 28, 29, 30, 31) . The average RNFL thickness was determined to be between 91.08 and 109.3 μm in the opposite eye of patients with MS and optical neuritis (20, 21, 22, 26, 30, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42) . In MS patients with no clinical record of optical neuritis, the average RNFL thickness was between 93.9 and 110.9 μm (28, 30, 36, 40, 43 ). These fi ndings are consistent with the previous records of lasting subclinical structural damage and axon loss, which was observed in magnetic resonance images of MS patients (44, 45) . This supports the hypothesis that early treatment of MS can prevent progressive subclinical axon loss (46) .
OCT and multiple cclerosis
RNFL thickness and multiple sclerosis
Very few studies were focused on quantifying RNFL thickness in patients with well-defi ned MS. In fact, most OCT studies included patients with and without a history of optical neuritis, and combined the results obtained on the opposite eye (considered as asymptomatic) of the patients with previous optical neuritis and the results from the eyes of patients with no history of optical neuritis. In spite of this, almost all of these studies proved that there was a thinning of RNFL in the eyes of MS patients when compared with the eyes of healthy subjects. The eyes with a previous episode of optical neuritis had a thinner RNFL than the unaffected eyes of MS patients, who also had a thinner RNFL than the eyes of healthy subjects (47) .
RNFL thickness after recovery from optical neuritis and the risk of multiple sclerosis
In 2008, Costello et al (48) found that RNFL thickness after an episode of isolated optical neuritis can not be used to predict the risk of MS. During the average period of 34 months, they subsequently prospectively followed 50 patients with a single unilateral episode of optical neuritis with no history of MS, and compared RNFL thickness of affected and unaffected eyes during 1 or 2 years after the development of optical neuritis; in 21 out of the 50 patients, clinically defi nitive MS developed. After a year of following, the RNFL of the affected eyes was thicker in patients with clinically defi nitive MS (89 μm) vs. the patients with no MS (78 μm). The authors accounted for this surprising result by the fact that the study patients with no MS had more severe optical neuritis than the MS patients; this proves that RNFL thinning is mostly related to the severity of optical neuritis and the loss of sight and it does not help predict the subsequent risk of MS.
RNFL thickness and the degree of severity of multiple sclerosis
To a large extent, RNFL atrophy is connected with the physical damage evaluated on the Expanded Disability Status Scale (EDSS) (19, 31, 49, 50) and longer duration of the disease (19, 31) . One of the studies, however, did not confi rm any mutual relationship between RNFL thickness and EDSS (19) . In a comparison of patients with an active course of the disease with neurologically stabilized patients, the RNFL in the temporal quadrant during the longer observation of MS patients thinned more signifi cantly in the former group (31, 50) . The average thinning of the total and temporal thickness of RNFL is lesser in patients who received immunomodulatory therapy within 0-24 months (31).
RNFL thickness and the various forms of MS
It appears that the rate of RNFL thinning observed in MS patients is affected by the subtype of MS. The patients with progressive forms of MS tend to suffer from a higher rate of RNFL thinning than patients with relapsing-remitting form of MS (RRMS) (30) . Another study only found temporal quadrant RNFL thinning in patients with primary progressive MS (PPMS), while the group of patients with secondary progressive MS (SPMS) had a more signifi cant RNFL thinning in the entire central, upper and temporal quadrants (36). When compared with healthy control subjects, the temporal quadrant was thinned in patients with PPMS, SPMS and also in clinically isolated syndromes (CIS). On the basis of these fi ndings, it can be assumed that axon damage happens in the early stages of the disease (31). Costello et al (33) compared the RNFL thickness in patients with isolated optical neuritis, patients with RRMS and patients with SPMS, observed during a period of more than two years. The average RNFL thickness in eyes after an episode of optical neuritis was similar in all groups after one or two years of study, while temporal RNFL was thinner in both MS groups when compared with isolated optical neuritis patients. In unaffected eyes, the SPMS patients had a thinner RNFL after one and two years when compared with RRMS patients and isolated optical neuritis patients. After two years, the unaffected eyes of RRMS patients had thinner temporal RNFL than the unaffected eyes of isolated optical neuritis patients.
These results suggest that RNFL thickness measurements (mainly in the temporal quadrant) in the unaffected eyes of MS patients may help discern the MS subtype and predict the progression and severity of MS (51) .
RNFL thickness and visual evoked potentials
The visual evoked potential (VEP) latency is more sensitive in expressing optic nerve damage than RNFL thickness (52) . In studies, there was a strong correlation between RNFL thickness and VEP amplitude; however, the results of evaluation of the relationship between axon loss measured through OCT and VEP latency were contradictory (20, 53) .
RNFL thickness and magnetic resonance of the brain
In MS patients, a large part of permanent invalidity is conditioned by axonal degeneration. Axonal loss happens as early as the fi rst stages of MS (1, 2) . Even though conventional MRI techniques are sensitive to the infl ammatory process (T2-weighted lesions), they do not specifi cally refl ect axonal damage (54) . MRI does not allow us to look into the process of subclinical optical neuropathy or to see the neurodegenerative effects on the retina, which are the result of optical neuropathy. RNFL thickness measurements using OCT could become a surrogate outcome marker for brain atrophy in MS (24) . The process of RNFL thinning correlates with the atrophy of the optic nerve, which can be measured by conventional MRI devices (55) as well as by magnetization transfer ratio (MTR) (31, 56) . In their study, Sepulcre et al (31) showed a slightly signifi cant correlation of RNFL thickness with the volume of white and gray brain matter, measured using conventional MRI, but not with the T1 and T2 volumes or the gadolinium enhanced lesions. A similar study proved that there was a relationship between RNFL thickness and the normalized volume of brain and white matter (40) . The study also suggested that a larger number of T2 lesions correlated with thinner RNFL. The correlation between RNFL thickness and MRI measurements of brain atrophy was more signifi cant in the subset of patients with no clinical history of optical neuritis than in those who suffered an episode of optical neuritis in the past (40) . In yet another study, there was independent correlation between RNFL thickness and the brain parenchymal fraction (BPF) obtained using high-resolution anatomical MRI. This study also found that there was a correlation between BPF and EDSS (50) . Later, a correlation between RNFL thickness, volume of T1 and T2 lesions, gray matter atrophy, MTR and diffusion tensor imaging measures (DTI) measurements in MS patients with or without a history of optical neuropathy was also discovered (34) . These MRI parameters also correlated with low-contrast measurements of visual acuity, which are a sensitive marker of optic nerve dysfunction in MS. Gordon-Lipkin et al (54) showed that there was a relationship between RNFL thickness and overall brain atrophy. In MS patients, there was a signifi cant relation between RNFL thickness, value of cerebral parenchyma component, volume of cerebrospinal fl uid and EDSS score; it was not, however, related with the white and gray matter volumes. The authors believe that the results were partially infl uenced by the fact that the damage in the brain is fi rst allocated to white matter. In subset analysis, a signifi cant relationship was discovered in RRMS patients, but no such relationship was found in SPMS patients; this could be caused by the fact that most SPMS patients have more spinal lesions than cerebral ones.
Can RNFL thickness be used as an outcome marker in clinical studies with MS?
Some authors suggest that RNFL thickness measurements using OCT could be a better means to detect and monitor axon loss in MS than MRI. The interpretation of OCT exam results demands a good grasp of the technique and the device, as well as correlation with comprehensive eye examination. OCT resolution is more sensitive than brain MRI in evaluating early axon loss. As there is no myelin in the retina, RNFL measurements do not depend on myelin disorders and can refl ect axon loss and thinning only. The fact that RNFL consists not only of axons but also of supporting tissue explains why the thickness of peripapillary RNFL in about 40 μm even in patients with complete atrophy of the optic nerve atrophy and light sensitivity (57) . It is comparatively easy to correlate OCT fi ndings with visual functions measured using verifi ed tools, like the visual acuity exam, low-contrast visual acuity measurements, contrast sensitivity, color perception, fi eld of vision and visual evoked potential measurements. There is a relationship between RNFL thinning observed using OCT and abnormalities in visual functions (23, 25) .
Ongoing studies and clinical trials now include measurements of RNFL thickness using standardized OCT protocols as their baseline measurements. If axon degeneration could be prevented using neuroprotectives, it could be expected to be refl ected in unchanged RNFL thickness in OCT measurements. Even though there are estimates of potential RNFL thinning after episodes of acute optical neuritis in MS (23) , it is equally important to know the estimated rate of RNFL thinning in MS without acute optical neuritis, in order to determine whether the neuroprotective drug in fact prevents axon degeneration. OCT has several important characteristics which make this imaging method a good potential surrogate outcome marker for the evaluation of the degree of axon damage in clinical studies.
Conclusion
OCT fulfi lls the requirement for a simple method which can evaluate axon integrity in MS through RNFL imaging. OCT can become a useful tool for following the progression of the disease in MS patients. It can improve our understanding of the effects of different therapies on MS patients and has the potential to become a surrogate outcome marker in studies examining the neuroprotective effect of drugs in MS. OCT can shed new light on the pathophysiology of MS, improve our understanding thereof, and thus contribute to the improvement in the clinical treatment of MS.
